Next Quarterly Earnings
Wednesday, November 4, 2026
CW 45
After-Hours
In 69 days
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical is a US-based biopharmaceutical company dedicated to the development and commercialization of transformative medicines for rare and ultra-rare genetic diseases. The company focuses on innovative therapeutic approaches, including gene therapies and other novel biologics, to offer patients worldwide new treatment options and improved quality of life.
Frequently asked questions
When will Ultragenyx Pharmaceutical report its next quarterly earnings?
Ultragenyx Pharmaceutical is scheduled to report its next quarterly earnings on 11/04/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
When did Ultragenyx Pharmaceutical last report quarterly earnings?
Ultragenyx Pharmaceutical last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at -0.90 USD.
How does Ultragenyx Pharmaceutical stock react to earnings?
Across its last 3 earnings reports, Ultragenyx Pharmaceutical stock moved by ±6.1% on average the following day. The largest reaction was -12.7% on 02/12/2026; 1 of 3 reactions were positive.
How often has Ultragenyx Pharmaceutical beaten expectations?
Ultragenyx Pharmaceutical has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
How do I add the Ultragenyx Pharmaceutical earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±6.1%
Avg. next-day move
-12.7%
Largest move (02/12/2026)
33.3%
Share of positive reactions
±5.6%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
2/5
Quarters above estimates
40%
Beat rate
-3%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Ultragenyx Pharmaceutical
Country
🇺🇸
More Financial Information